TVTX

Travere Therapeutics, Inc. Common Stock

$47.18 -1.21%

Recent alerts on TVTX

All signals →

News Travere inks licensing deal worth up to $1.1B with China’s Everest Medicines

Insider trade Sale by Coughlin Timothy

News Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

Insider trade Sale by Jula Inrig (CHIEF MEDICAL OFFICER)

Insider trade Sale by Roy D. Baynes

Insider trade Sale by Meckler Jeffrey A

Insider trade Sale by William E. Rote (Chief Research Officer)

Insider trade Sale by Elizabeth E Reed (Chief Legal Officer and GC)

Insider trade Sale by Eric M Dube (CHIEF EXECUTIVE OFFICER)

Insider trade Sale by Christopher R. Cline (CHIEF FINANCIAL OFFICER)

Insider trade Sale by Peter Heerma (CHIEF COMMERCIAL OFFICER)

News Here are the major earnings after the close Monday

News Travere Therapeutics plans $400M convertible notes offering

Insider trade Sale by Roy D. Baynes

SEC filing TVTX Reports $124.5M Revenue, $4.1M Adjusted Net Income, FDA Approves FILSPARI for FSGS, Launches Phase 3 HARMONY Study

News Organon & Co is the best performing healthcare stock in April

Insider trade Sale by William E. Rote (Chief Research Officer)

Insider trade Sale by William E. Rote (Chief Research Officer)

Insider trade Sale by LYONS GARY A

Insider trade Sale by Sandra Calvin (SVP, CHIEF ACCOUNTING OFFICER)

Insider trade Sale by Roy D. Baynes

Insider trade Sale by Peter Heerma (CHIEF COMMERCIAL OFFICER)

Insider trade Sale by Eric M Dube (CHIEF EXECUTIVE OFFICER)

Insider trade Sale by Elizabeth E Reed (Chief Legal Officer and GC)

Insider trade Sale by Jula Inrig (CHIEF MEDICAL OFFICER)

Get push alerts for TVTX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS